Human Microbiota Network: Unveiling Potential Crosstalk Between the Different Microbiota Ecosystems and Their Role in Health and Disease
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Official Nh Dhhs Health Alert
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected. -
The Gut Microbiota and Inflammation
International Journal of Environmental Research and Public Health Review The Gut Microbiota and Inflammation: An Overview 1, 2 1, 1, , Zahraa Al Bander *, Marloes Dekker Nitert , Aya Mousa y and Negar Naderpoor * y 1 Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne 3168, Australia; [email protected] 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 4072, Australia; [email protected] * Correspondence: [email protected] (Z.A.B.); [email protected] (N.N.); Tel.: +61-38-572-2896 (N.N.) These authors contributed equally to this work. y Received: 10 September 2020; Accepted: 15 October 2020; Published: 19 October 2020 Abstract: The gut microbiota encompasses a diverse community of bacteria that carry out various functions influencing the overall health of the host. These comprise nutrient metabolism, immune system regulation and natural defence against infection. The presence of certain bacteria is associated with inflammatory molecules that may bring about inflammation in various body tissues. Inflammation underlies many chronic multisystem conditions including obesity, atherosclerosis, type 2 diabetes mellitus and inflammatory bowel disease. Inflammation may be triggered by structural components of the bacteria which can result in a cascade of inflammatory pathways involving interleukins and other cytokines. Similarly, by-products of metabolic processes in bacteria, including some short-chain fatty acids, can play a role in inhibiting inflammatory processes. In this review, we aimed to provide an overview of the relationship between the gut microbiota and inflammatory molecules and to highlight relevant knowledge gaps in this field. -
A Taxonomic Note on the Genus Lactobacillus
Taxonomic Description template 1 A taxonomic note on the genus Lactobacillus: 2 Description of 23 novel genera, emended description 3 of the genus Lactobacillus Beijerinck 1901, and union 4 of Lactobacillaceae and Leuconostocaceae 5 Jinshui Zheng1, $, Stijn Wittouck2, $, Elisa Salvetti3, $, Charles M.A.P. Franz4, Hugh M.B. Harris5, Paola 6 Mattarelli6, Paul W. O’Toole5, Bruno Pot7, Peter Vandamme8, Jens Walter9, 10, Koichi Watanabe11, 12, 7 Sander Wuyts2, Giovanna E. Felis3, #*, Michael G. Gänzle9, 13#*, Sarah Lebeer2 # 8 '© [Jinshui Zheng, Stijn Wittouck, Elisa Salvetti, Charles M.A.P. Franz, Hugh M.B. Harris, Paola 9 Mattarelli, Paul W. O’Toole, Bruno Pot, Peter Vandamme, Jens Walter, Koichi Watanabe, Sander 10 Wuyts, Giovanna E. Felis, Michael G. Gänzle, Sarah Lebeer]. 11 The definitive peer reviewed, edited version of this article is published in International Journal of 12 Systematic and Evolutionary Microbiology, https://doi.org/10.1099/ijsem.0.004107 13 1Huazhong Agricultural University, State Key Laboratory of Agricultural Microbiology, Hubei Key 14 Laboratory of Agricultural Bioinformatics, Wuhan, Hubei, P.R. China. 15 2Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience 16 Engineering, University of Antwerp, Antwerp, Belgium 17 3 Dept. of Biotechnology, University of Verona, Verona, Italy 18 4 Max Rubner‐Institut, Department of Microbiology and Biotechnology, Kiel, Germany 19 5 School of Microbiology & APC Microbiome Ireland, University College Cork, Co. Cork, Ireland 20 6 University of Bologna, Dept. of Agricultural and Food Sciences, Bologna, Italy 21 7 Research Group of Industrial Microbiology and Food Biotechnology (IMDO), Vrije Universiteit 22 Brussel, Brussels, Belgium 23 8 Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, Ghent, 24 Belgium 25 9 Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada 26 10 Department of Biological Sciences, University of Alberta, Edmonton, Canada 27 11 National Taiwan University, Dept. -
Molecular Assessment of Bacterial Vaginosis by Lactobacillus Abundance and Species Diversity Joke A
Western University Scholarship@Western Microbiology & Immunology Publications Microbiology & Immunology Department 4-2016 Molecular Assessment of Bacterial Vaginosis by Lactobacillus Abundance and Species Diversity Joke A. M. Dols VU University Amsterdam Douwe Molenaar VU University Amsterdam Jannie J. van der Helm Public Health Service of Amsterdam Martien P. M. Caspers Netherlands Organisation for Applied Scientific Research Alie de Kat Angelino-Bart Netherlands Organisation for Applied Scientific Research See next page for additional authors Follow this and additional works at: https://ir.lib.uwo.ca/mnipub Part of the Immunology and Infectious Disease Commons, and the Microbiology Commons Citation of this paper: Dols, Joke A. M.; Molenaar, Douwe; van der Helm, Jannie J.; Caspers, Martien P. M.; de Kat Angelino-Bart, Alie; Schuren, Frank H. J.; Speksnijder, Adrianus G. C. L.; Westerhoff, Hans V.; Richardus, Jan Hendrik; Boon, Mathilde E.; Reid, Gregor; de Vries, Henry J. C.; and Kort, Remco, "Molecular Assessment of Bacterial Vaginosis by Lactobacillus Abundance and Species Diversity" (2016). Microbiology & Immunology Publications. 50. https://ir.lib.uwo.ca/mnipub/50 Authors Joke A. M. Dols, Douwe Molenaar, Jannie J. van der Helm, Martien P. M. Caspers, Alie de Kat Angelino-Bart, Frank H. J. Schuren, Adrianus G. C. L. Speksnijder, Hans V. Westerhoff, Jan Hendrik Richardus, Mathilde E. Boon, Gregor Reid, Henry J. C. de Vries, and Remco Kort This article is available at Scholarship@Western: https://ir.lib.uwo.ca/mnipub/50 Dols et al. BMC Infectious Diseases (2016) 16:180 DOI 10.1186/s12879-016-1513-3 RESEARCH ARTICLE Open Access Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity Joke A. -
BD™ Gardnerella Selective Agar with 5% Human Blood
INSTRUCTIONS FOR USE – READY-TO-USE PLATED MEDIA PA-254094.06 Rev.: July 2014 BD Gardnerella Selective Agar with 5% Human Blood INTENDED USE BD Gardnerella Selective Agar with 5% Human Blood is a partially selective and differential medium for the isolation of Gardnerella vaginalis from clinical specimens. PRINCIPLES AND EXPLANATION OF THE PROCEDURE Microbiological method. Gardnerella vaginalis is considered to be one of the organisms causing vaginitis.1-4 Although the organism may be present in a high percentage of normal women in the vaginal flora, its importance as a cause of non-specific vaginitis (also called bacterial vaginosis) has never been questioned. In symptomatic women, G. vaginalis frequently is associated with anaerobes such as Prevotella bivia, P. disiens, Mobiluncus, Peptostreptococcus, and/or others which are a regular part of the urethral or intestinal, but not vaginal flora. In non-specific vaginitis, normal Lactobacillus flora is reduced or absent. Gardnerella vaginalis is considered to be the indicator organism for non-specific vaginitis which, in fact, is a polymicrobial infection.3,4 Although non- culture methods such as a direct Gram stain have been recommended in recent years for genital specimens, culture is still preferred by many laboratories.1,5 G. vaginalis may also be responsible for a variety of other diseases such as preterm birth, chorioamnionitis, urinary tract infections, newborn infections, and septicemia.6 The detection of the organism on routinely used media is difficult since Gardnerella and other -
Genomic Homogeneity Between Mycobacterium Avium Subsp. Avium and Mycobacterium Avium Subsp
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Agriculture: Agricultural Publications from USDA-ARS / UNL Faculty Research Service, Lincoln, Nebraska 2003 Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates John P. Bannantine ARS-USDA, [email protected] Qing Zhang 2University of Minnesota, Minneapolis, [email protected] Ling-Ling Li University of Minnesota, Minneapolis, [email protected] Vivek Kapur University of Minnesota, Minneapolis, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub Bannantine, John P.; Zhang, Qing; Li, Ling-Ling; and Kapur, Vivek, "Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates" (2003). Publications from USDA-ARS / UNL Faculty. 2372. https://digitalcommons.unl.edu/usdaarsfacpub/2372 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. BMC Microbiology BioMed Central Research article Open Access Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their -
Nomenclature of Bacteria with Special Reference to the Order Actinomycetales'
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY VOL. 21, No. 2 April 1971, pp. 197-206 Printed in U.S.A. Copyright 0 1971 International Association of Microbiological Societies Nomenclature of Bacteria with Special Reference to the Order Actinomycetales' THOMAS G. PRIDHAM Northern Regional Research Laboratory,z Peoria, Illinois 61604 The number of names for streptomycetes that is in the scientific literature now is exceeded only by those for organisms placed in the genus Bacillus Cohn 1872. The genus Streptomyces Waksman and Henrici 1943 may well rank in first place if names in the patent and quasiscientific literature are included. The overwhelming number of names and the lack of a precise definition of a particular species or subspecies, of type or neotype strains, and of certain essential details have brought about problems in assessing the status of many names. The major problems encountered in a 2-year study are discussed, and a simple format is suggested, use of which may help to clarify future nomenclature. Twelve years ago, I presented (29) before ture of Bacteria (20); type strains, where these the First Latin-American Congress for Micro- can be located and obtained, are being as- biology held at Mexico, D.F., some suggestions sembled and recharacterized (35 -38) through on establishing a logical order in streptomycete the International Streptomyces Project, and a classification. minumum set of substrata and tests have been (i) Compilation and evaluation of available recommended for description of A ctino- literature on nomenclature and characterization mycetales in patents (1 1, 12). of streptomycetes. One item upon which insufficient attention (ii) Decision on the proper code of nomen- has been focused is nomenclature. -
Glycomyces, a New Genus of the Actinomycetales D
INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1985, p. 417-421 Vol. 35, No. 4 0020-7713/85/040417-05$02.00/0 Glycomyces, a New Genus of the Actinomycetales D. P. LABEDA,l* R. T. TESTA,2 M. P. LECHEVALIER,3 AND H. A. LECHEVALIER3 U. S. Department of Agriculture, Agricultural Research Sewice, Northern Regional Research Center, Peoria, Illinois 61604'; Medical Research Division, American Cyanamid Co., Pearl River, New York 109652; and Waksman Institute of Microbiology, Rutgers, The State University, Piscataway, New Jersey 088543 We describe two species of the new genus Glycomyces, Glycomyces harbinensis sp. nov. and Glycomyces rutgersensis sp. nov. Members of this genus are aerobic, produce nonfragmenting vegetative hyphae, and form chains of conidia on aerial sporophores. The cell walls are type I1 (rneso-diaminopimelic acid and glycine are present), and the whole-cell sugar patterns are type D (xylose and arabinose are present). The phospholipid pattern of both species is type P-I (no nitrogenous phospholipids). The guanine-plus-cytosine content of the deoxyribonucleic acid ranges from 71 to 73 mol%. The type strain of type species G. harbinensis is strain NRRL 15337 (= LL-D05139), and the type strain of G. rutgersensis is strain NRRL B-16106 (= LL-1-20). During the course of isolation of actinomycete strains Gordon et al. (8). Esculin hydrolysis was evaluated by the from soil for an antibiotic screening program, a novel isolate method of Williams et al. (27), and Tween 80 hydrolysis was was obtained from a soil sample from Harbin, People's evaluated by the method of Sierra (26). Phosphatase activity Republic of China. -
Biofilm Degradation of Nontuberculous Mycobacteria
processes Article Biofilm Degradation of Nontuberculous Mycobacteria Formed on Stainless Steel Following Treatment with Immortelle (Helichrysum italicum) and Common Juniper (Juniperus communis) Essential Oils Dolores Peruˇc 1,* , Dalibor Brozni´c 2 , Željka Maglica 3, Zvonimir Marijanovi´c 4, Ljerka Karleuša 5 and Ivana Gobin 1 1 Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia; [email protected] 2 Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia; [email protected] 3 Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia; [email protected] 4 Department of Food Technology and Biotechnology, Faculty of Chemistry and Technology, University of Split, 21000 Split, Croatia; [email protected] 5 Department of Physiology and Immunology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia; [email protected] * Correspondence: [email protected]; Tel.: +385-(0)51-651-145; Fax: +385-(0)51-651-177 Abstract: Nontuberculous mycobacteria, like other opportunistic premise plumbing pathogens, pro- duce resistant biofilms on various surfaces in the plumbing system including pipes, tanks, and fittings. Citation: Peruˇc,D.; Brozni´c,D.; Since standard methods of water disinfection are ineffective in eradicating biofilms, research into new Maglica, Ž.; Marijanovi´c,Z.; Karleuša, agents is necessary. Essential oils (EOs) have great potential as anti-biofilm agents. Therefore, the pur- L.; Gobin, I. Biofilm Degradation of pose of this research was to investigate the potential anti-biofilm effect of common juniper (Juniperus Nontuberculous Mycobacteria communis) and immortelle (Helichrysum italicum) EOs. Minimum inhibitory concentrations (MIC), Formed on Stainless Steel Following Treatment with Immortelle minimum bactericidal concentrations (MBC), and minimum effective concentrations of EOs on My- (Helichrysum italicum) and Common cobacterium avium, M. -
Downloaded from 3
Philips et al. BMC Genomics (2020) 21:402 https://doi.org/10.1186/s12864-020-06810-9 RESEARCH ARTICLE Open Access Analysis of oral microbiome from fossil human remains revealed the significant differences in virulence factors of modern and ancient Tannerella forsythia Anna Philips1, Ireneusz Stolarek1, Luiza Handschuh1, Katarzyna Nowis1, Anna Juras2, Dawid Trzciński2, Wioletta Nowaczewska3, Anna Wrzesińska4, Jan Potempa5,6 and Marek Figlerowicz1,7* Abstract Background: Recent advances in the next-generation sequencing (NGS) allowed the metagenomic analyses of DNA from many different environments and sources, including thousands of years old skeletal remains. It has been shown that most of the DNA extracted from ancient samples is microbial. There are several reports demonstrating that the considerable fraction of extracted DNA belonged to the bacteria accompanying the studied individuals before their death. Results: In this study we scanned 344 microbiomes from 1000- and 2000- year-old human teeth. The datasets originated from our previous studies on human ancient DNA (aDNA) and on microbial DNA accompanying human remains. We previously noticed that in many samples infection-related species have been identified, among them Tannerella forsythia, one of the most prevalent oral human pathogens. Samples containing sufficient amount of T. forsythia aDNA for a complete genome assembly were selected for thorough analyses. We confirmed that the T. forsythia-containing samples have higher amounts of the periodontitis-associated species than the control samples. Despites, other pathogens-derived aDNA was found in the tested samples it was too fragmented and damaged to allow any reasonable reconstruction of these bacteria genomes. The anthropological examination of ancient skulls from which the T. -
THE HUMAN MICROBIOTA: the ROLE of MICROBIAL COMMUNITIES in HEALTH and DISEASE La Microbiota Humana: Comunidades Microbianas En La Salud Y En La Enfermedad
ACTA BIOLÓGICA COLOMBIANA http://www.revistas.unal.edu.co/index.php/actabiol SEDE BOGOTÁ FACULTAD DE CIENCIAS ARTÍCULODEPARTAMENTO DE DE REVISIÓN BIOLOGÍA INVITADO / INVITED REVIEW THE HUMAN MICROBIOTA: THE ROLE OF MICROBIAL COMMUNITIES IN HEALTH AND DISEASE La microbiota humana: comunidades microbianas en la salud y en la enfermedad Luz Elena BOTERO1,2, Luisa DELGADO-SERRANO3,4, Martha Lucía CEPEDA HERNÁNDEZ3, Patricia DEL PORTILLO OBANDO3, María Mercedes ZAMBRANO EDER3. 1 Facultad de Medicina, Universidad Pontificia Bolivariana. Calle 78B no. 72A-109, Bloque B, Piso 5. Medellín, Colombia. 2 Unidad de Bacteriología y Micobacterias, Corporación para Investigaciones Biológicas, Unidad Pontificia Bolivariana. Carrera 72A no. 78B-141. Medellín, Colombia. 3 Corporación Corpogen. Carrera 5 no. 66A-34. Bogotá D.C., Colombia. 4 Centro de Bioinformática y Biología Computacional- BIOS. Carrera 15B no. 161. Manizales, Colombia. For correspondence. [email protected] Received: 22nd March 2015, Returned for revision: 14th April 2015, Accepted: 10th July 2015. Associate Editor: Nubia Estela Matta Camacho. Citation / Citar este artículo como: Botero LE, Delgado-Serrano L, Cepeda ML, Del Portillo P, Zambrano MM. The human microbiota: the role of microbial communities in health and disease. Acta biol. Colomb. 2016;21(1):5-15. doi: http://dx.doi.org/10.15446/abc.v21n1.49761 ABSTRACT During the last decade, there has been increasing awareness of the massive number of microorganisms, collectively known as the human microbiota, that are associated with humans. This microbiota outnumbers the host cells by approximately a factor of ten and contains a large repertoire of microbial genome-encoded metabolic processes. The diverse human microbiota and its associated metabolic potential can provide the host with novel functions that can influence host health and disease status in ways that still need to be analyzed. -
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
diseases Review From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation Carole Nicco 1 , Armelle Paule 2, Peter Konturek 3 and Marvin Edeas 1,* 1 Cochin Institute, INSERM U1016, University Paris Descartes, Development, Reproduction and Cancer, Cochin Hospital, 75014 Paris, France; [email protected] 2 International Society of Microbiota, 75002 Paris, France; [email protected] 3 Teaching Hospital of the University of Jena, Thuringia-Clinic Saalfeld, 07318 Saalfeld, Germany; [email protected] * Correspondence: [email protected] Received: 6 March 2020; Accepted: 10 April 2020; Published: 15 April 2020 Abstract: Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh or frozen fecal microorganisms from a healthy donor into the intestinal tract of diseased patients. At this time, in according to healthcare authorities, FMT is mainly used to treat recurrent Clostridium difficile. Despite the existence of a few existing stool banks worldwide and many studies of the FMT, there is no standard method for producing material for FMT, and there are a multitude of factors that can vary between the institutions. The main constraints for the therapeutic uses of FMT are safety concerns and acceptability. Technical and logistical issues arise when establishing such a non-standardized treatment into clinical practice with safety and proper governance. In this context, our manuscript describes a process of donor safety screening for FMT compiling clinical and biological examinations, questionnaires and interviews of donors.